American Society of Hirudotherapy

Quality Assurance in Platelet Function Testing.

Review published in Clinics in laboratory medicine (2026)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewClinical TrialsDrug DevelopmentSmock et al. · Clinics in laboratory medicine, 2026

Abstract

Platelets play a crucial role in primary hemostasis. Congenital and acquired platelet disorders may be associated with bleeding. High-quality laboratory assessment of platelets is crucial for patient care. Multiple methods have been developed to assess platelet function. While several guidelines have been published related to platelet function testing, surveys demonstrate wide variation in practices. Preanalytical variables such as patient medication use, collection, transport, and storage impact testing results. Test interpretation requires appropriate reference intervals and an understanding of the impact of thrombocytopenia on results. Internal and external quality assessments aid laboratories in monitoring the performance of platelet function assays.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsHumansPlatelet Function TestsBlood PlateletsQuality Assurance, Health CareBlood Platelet Disorders

Summary

Platelets play a crucial role in primary hemostasis. Congenital and acquired platelet disorders may be associated with bleeding. High-quality laboratory assessment of platelets is crucial for patient care. Multiple methods have been developed to assess platelet function. While several guidelines have been published related to platelet function testing, surveys demonstrate wide variation in practices.

Why This Matters for Hirudotherapy

This review surveys quality assurance in laboratory platelet function testing, noting that platelets are central to primary hemostasis, that congenital and acquired platelet disorders may cause bleeding, that high-quality platelet assessment is crucial for patient care, and that despite published guidelines, surveys show wide variation in practice. It emphasizes that preanalytical variables (patient medication use, collection, transport, storage), appropriate reference intervals, the impact of thrombocytopenia, and internal/external quality assessment all critically affect result interpretation. For hirudotherapy this is contextual support for the clinical-evidence and laboratory-safety side of the field: assessing platelet function is part of evaluating bleeding risk around leech application, and leech secretome components (e.g., platelet-aggregation inhibitors such as calin and saratin, described elsewhere) target the very platelet function these assays measure. Caveat: this is a methodological laboratory review about test quality, not a study of hirudotherapy, leeches, or any therapeutic effect, so it bears only on how platelet-related safety testing should be performed and interpreted.

Citation

Quality Assurance in Platelet Function Testing.

Smock et al. · Clinics in laboratory medicine, 2026

Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.